Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LYNAVOY safely and effectively. See full prescribing information for LYNAVOY. LYNAVOY (linerixibat) tablets, for oral use Initial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
LYNAVOY is indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or active hepatic decompensation events (e.g. variceal hemorrhage, ascites, hepatic encephalopathy) [see Use in Specific Populations (8.7), Clinical Pharmacology (12.3)].
- generic_name
- linerixibat
- product_names
- Linerixibat
- ndc
- 69516-140, 69516-140-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en